|
Multiple sclerosis
Citations 351-360 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- CLINICAL/SCIENTIFIC NOTES
A rare, treatable cause of relapsing encephalopathy in an MS patient on interferon beta therapy
- Chris H. Polman, Paul H.P. Jansen, Cees Jansen, and Bernard M.J. Uitdehaag
Neurology 2003; 61: 719.
[Full text]
[PDF]
- ARTICLES
Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians
- F. R. Guerini, P. Ferrante, L. Losciale, D. Caputo, M. L. Lombardi, G. Pirozzi, V. Luongo, M. A. Sudomoina, T. V. Andreewski, A. D. Alekseenkov, A. N. Boiko, E. I. Gusev, and O. O. Favorova
Neurology 2003; 61: 520-526.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Interrupted therapy: Stopping and switching of the ß-interferons prescribed for MS
- Helen L. Tremlett and Joel Oger
Neurology 2003; 61: 551-554.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Clinical characteristics of responders to interferon therapy for relapsing MS
- E. Waubant, S. Vukusic, L. Gignoux, F. Durand- Dubief, I. Achiti, S. Blanc, C. Renoux, and C. Confavreux
Neurology 2003; 61: 184-189.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A mutated CCR5 gene may have favorable prognostic implications in MS
- Rami Kantor, Mary Bakhanashvili, and Anat Achiron
Neurology 2003; 61: 238-240.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
 -Fodrin autoantibodies in the differential diagnosis of MS and Sjögren syndrome
- J. de Seze, S. Dubucquoi, A. L. Fauchais, T. Matthias, D. Devos, G. Castelnovo, T. Stojkovic, D. Ferriby, E. Hachulla, P. Labauge, D. Lefranc, P. Y. Hatron, P. Vermersch, and T. Witte
Neurology 2003; 61: 268-269.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Chlamydia pneumoniae in children with MS: Frequency and quantity of intrathecal antibodies
- K. Rostasy, H. Reiber, D. Pohl, P. Lange, A. Ohlenbusch, H. Eiffert, M. Maass, and F. Hanefeld
Neurology 2003; 61: 125-128.
[Abstract]
[Full text]
[PDF]
- ARTICLES
The immune response against herpesvirus is more prominent in the early stages of MS
- P. Villoslada, C. Juste, M. Tintore, V. Llorenç, G. Codina, P. Pozo-Rosich, and X. Montalban
Neurology 2003; 60: 1944-1948.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
- M. Wylezinska, A. Cifelli, P. Jezzard, J. Palace, M. Alecci, and P. M. Matthews
Neurology 2003; 60: 1949-1954.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized controlled study of the acute and chronic effects of cooling therapy for MS
-
Neurology 2003; 60: 1955-1960.
[Abstract]
[Full text]
[PDF]
|
|
